A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3611-3619

  Qi, Qian ^a,b,c   Huang, Weishan ^a,b   Bai, Yuting ^a,b   Balmus, Gabriel ^b   Weiss, Robert S ^b   August, Avery ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Cornell University ^*  (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; FAS ANTIGEN; PROTEIN BAD; PROTEIN BAX; PROTEIN P53; PROTEIN TYROSINE KINASE; TEC KINASE ITK; TEC KINASE RLK; TEC KINASE TXK; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PLZF; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CYTOKINE RELEASE; DEVELOPMENT; ENZYME ACTIVITY; IMMUNE RESPONSE; INVARIANT NATURAL KILLER T CELL; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN LYMPHOCYTE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CYTOKINES; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PRIMARY CELL CULTURE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SPLEEN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84860330870     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102475     Document Type: Article

References (62)

1. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
2. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762. (Pubitemid 350102258)
3. Pasquier, B., L. Yin, M. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701. (Pubitemid 40395115)
4. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163: 4091-4094. (Pubitemid 29474468)
5. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345. (Pubitemid 40460564)
6. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
7. Kovalovsky, D., O. U. Uche, S. Eladad, R. M. Hobbs, W. Yi, E. Alonzo, K. Chua, M. Eidson, H. J. Kim, J. S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
8. Lazarevic, V., A. J. Zullo, M. N. Schweitzer, T. L. Staton, E. M. Gallo, G. R. Crabtree, and L. H. Glimcher. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-313.
9. Kunisaki, Y., Y. Tanaka, T. Sanui, A. Inayoshi, M. Noda, T. Nakayama, M. Harada, M. Taniguchi, T. Sasazuki, and Y. Fukui. 2006. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. J. Immunol. 176: 4640-4645.
10. Elewaut, D., R. B. Shaikh, K. J. Hammond, H. De Winter, A. J. Leishman, S. Sidobre, O. Turovskaya, T. I. Prigozy, L. Ma, T. A. Banks, et al. 2003. NIKdependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells. J. Exp. Med. 197: 1623-1633. (Pubitemid 36745338)
11. Finlay, D., A. Kelly, R. Clarke, L. Sinclair, M. Deak, D. Alessi, and D. Cantrell. 2010. Temporal differences in the dependency on phosphoinositide- dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells. J. Immunol. 185: 5973-5982.
12. Fedeli, M., A. Napolitano, M. Wong, A. Marcais, C. de Lalla, F. Colucci, M. Merkenschlager, P. Dellabona, and G. Casorati. 2009 Dicer-dependent microRNA pathway controls invariant NKT cell development. J. Immunol. 183: 2506-2512.
13. Matsuda, J. L., L. Gapin, S. Sidobre, W. C. Kieper, J. T. Tan, R. Ceredig, C. D. Surh, and M. Kronenberg. 2002. Homeostasis of V alpha 14i NKT cells. Nat. Immunol. 3: 966-974. (Pubitemid 35154011)
14. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20: 477-494. (Pubitemid 38482125)
15. Matsuda, J. L., Q. Zhang, R. Ndonye, S. K. Richardson, A. R. Howell, and L. Gapin. 2006. T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells. Blood 107: 2797-2805.
16. Yu, S., and M. T. Cantorna. 2008. The vitamin D receptor is required for iNKT cell development. Proc. Natl. Acad. Sci. USA 105: 5207-5212. (Pubitemid 351738535)
17. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018. (Pubitemid 32440726)
18. Akbari, O., P. Stock, E. H. Meyer, G. J. Freeman, A. H. Sharpe, D. T. Umetsu, and R. H. DeKruyff. 2008. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. J. Immunol. 180: 5448-5456.
19. Gordy, L., J. Bezbradica, A. Flyak, C. Spencer, A. Dunkle, J. Sun, A. Stanic, M. Boothby, Y. He, Z. Zhao, L. Van Kaer, and S. Joyce. 2011. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 187: 6335-6345.
20. Chung, Y., R. Nurieva, E. Esashi, Y. H. Wang, D. Zhou, L. Gapin, and C. Dong. 2008. A critical role of costimulation during intrathymic development of invariant NK T cells. J. Immunol. 180: 2276-2283.
21. Kishimoto, H., T. Ohteki, N. Yajima, K. Kawahara, M. Natsui, S. Kawarasaki, K. Hamada, Y. Horie, Y. Kubo, S. Arase, et al. 2007. The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 109: 3316-3324. (Pubitemid 46572519)
22. Jordan, M. S., J. E. Smith, J. C. Burns, J. E. Austin, K. E. Nichols, A. C. Aschenbrenner, and G. A. Koretzky. 2008. Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76. Immunity 28: 359-369. (Pubitemid 351343858)
23. Felices, M., and L. J. Berg. 2008. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J. Immunol. 180: 3007-3018.
24. Au-Yeung, B. B., and D. J. Fowell. 2007. A key role for Itk in both IFN gamma and IL-4 production by NKT cells. J. Immunol. 179: 111-119. (Pubitemid 46986524)
25. Sommers, C. L., R. L. Rabin, A. Grinberg, H. C. Tsay, J. Farber, and P. E. Love. 1999. A role for the Tec family tyrosine kinase Txk in T cell activation and thymocyte selection. J. Exp. Med. 190: 1427-1438.
26. Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4: 1-7.
27. Qi, Q., M. Xia, Y. Bai, S. Yu, M. Cantorna, and A. August. 2011. Interleukin-2inducible T cell kinase (Itk) network edge dependence for the maturation of iNKT cell. J. Biol. Chem. 286: 138-146.
28. Sahu, N., A. M. Venegas, D. Jankovic, W. Mitzner, J. Gomez-Rodriguez, J. L. Cannons, C. Sommers, P. Love, A. Sher, P. L. Schwartzberg, and A. August. 2008. Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses. J. Immunol. 181: 6125-6131.
29. Intlekofer, A. M., N. Takemoto, E. J. Wherry, S. A. Longworth, J. T. Northrup, V. R. Palanivel, A. C. Mullen, C. R. Gasink, S. M. Kaech, J. D. Miller, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244. (Pubitemid 43045635)
30. Berg, L. J. 2007. Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development. Nat. Rev. Immunol. 7: 479-485. (Pubitemid 46834846)
31. Hu, J., and A. August. 2008. Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development. J. Immunol. 180: 6544-6552.
32. Horai, R., K. L. Mueller, R. A. Handon, J. L. Cannons, S. M. Anderson, M. R. Kirby, and P. L. Schwartzberg. 2007. Requirements for selection of conventional and innate T lymphocyte lineages. Immunity 27: 775-785. (Pubitemid 350102265)
33. Broussard, C., C. Fleischacker, R. Horai, M. Chetana, A. M. Venegas, L. L. Sharp, S. M. Hedrick, B. J. Fowlkes, and P. L. Schwartzberg. 2006. Altered development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk and Rlk. [Published erratum appears in 2006 Immunity 25: 849.] Immunity 25: 93-104. (Pubitemid 44066833)
34. Atherly, L. O., J. A. Lucas, M. Felices, C. C. Yin, S. L. Reiner, and L. J. Berg. 2006. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Immunity 25: 79-91. (Pubitemid 44066834)
35. Hu, J., N. Sahu, E. Walsh, and A. August. 2007. Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk. Eur. J. Immunol. 37: 2892-2899. (Pubitemid 47578308)
36. Readinger, J. A., K. L. Mueller, A. M. Venegas, R. Horai, and P. L. Schwartzberg. 2009. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunol. Rev. 228: 93-114.
37. Gadue, P., and P. L. Stein. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169: 2397-2406. (Pubitemid 34920982)
38. August, A., A. Sadra, B. Dupont, and H. Hanafusa. 1997. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proc. Natl. Acad. Sci. USA 94: 11227-11232. (Pubitemid 27450980)
39. Debnath, J., M. Chamorro, M. J. Czar, E. M. Schaeffer, M. J. Lenardo, H. E. Varmus, and P. L. Schwartzberg. 1999. rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol. Cell. Biol. 19: 1498-1507. (Pubitemid 29046891)
40. Schaeffer, E. M., J. Debnath, G. Yap, D. McVicar, X. C. Liao, D. R. Littman, A. Sher, H. E. Varmus, M. J. Lenardo, and P. L. Schwartzberg. 1999. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284: 638-641. (Pubitemid 29289587)
41. Lucas, J. A., M. Felices, J. W. Evans, and L. J. Berg. 2007. Subtle defects in preTCR signaling in the absence of the Tec kinase Itk. J. Immunol. 179: 7561-7567.
42. Castillo, E., L. Acero, S. Stonier, D. Zhou, and K. Schluns. 2010. Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation. Blood 116: 2494-2503.
43. Raberger, J., A. Schebesta, S. Sakaguchi, N. Boucheron, K. Blomberg, A. Berglöf, T. Kolbe, C. Smith, T. Rülicke, and W. Ellmeier. 2008. The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc. Natl. Acad. Sci. USA 105: 17919-17924.
44. Hong, M., M. D. Lai, Y. S. Lin, and M. Z. Lai. 1999. Antagonism of p53dependent apoptosis by mitogen signals. Cancer Res. 59: 2847-2852. (Pubitemid 29283122)
45. Das, M., F. Jiang, H. Sluss, C. Zhang, K. Shokat, R. Flavell, and R. Davis. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl. Acad. Sci. USA 104: 15759-15764. (Pubitemid 350035373)
46. Lu, Y., B. Cuevas, S. Gibson, H. Khan, R. LaPushin, J. Imboden, and G. B. Mills. 1998. Phosphatidylinositol 3-kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinase EMT/ITK/TSK: functional and physical interaction of EMT with phosphatidylinositol 3-kinase. J. Immunol. 161: 5404-5412. (Pubitemid 28519102)
47. Leite-de-Moraes, M. C., A. Herbelin, C. Gouarin, Y. Koezuka, E. Schneider, and M. Dy. 2000. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 165: 4367-4371.
48. Chan, H., D. P. Bartos, and L. B. Owen-Schaub. 1999. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50p65 recruitment. Mol. Cell. Biol. 19: 2098-2108. (Pubitemid 29098268)
49. Li, X. R., A. S. Chong, J. Wu, K. A. Roebuck, A. Kumar, J. E. Parrillo, U. R. Rapp, R. P. Kimberly, J. W. Williams, and X. Xu. 1999. Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor. CD3 complex-stimulated T cells. J. Biol. Chem. 274: 35203-35210. (Pubitemid 129509578)
50. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W. W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15: 3032-3040.
51. Kuribayashi, K., and W. S. El-Deiry. 2008. Regulation of programmed cell death by the p53 pathway. Adv. Exp. Med. Biol. 615: 201-221.
52. Kuribayashi, K., N. Finnberg, and W. S. El-Deiry. 2008. Studying p53-dependent cell death in vitro and in vivo. Methods Enzymol. 446: 159-173.
53. Phan, R. T., and R. Dalla-Favera. 2004. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 432: 635-639. (Pubitemid 39626271)
54. Schaeffer, E. M., G. S. Yap, C. M. Lewis, M. J. Czar, D. W. McVicar, A. W. Cheever, A. Sher, and P. L. Schwartzberg. 2001. Mutation of Tec family kinases alters T helper cell differentiation. Nat. Immunol. 2: 1183-1188. (Pubitemid 33130154)
55. Czar, M. J., J. Debnath, E. M. Schaeffer, C. M. Lewis, and P. L. Schwartzberg. 2001. Biochemical and genetic analyses of the Tec kinases Itk and Rlk/Txk. Biochem. Soc. Trans. 29: 863-867. (Pubitemid 33131795)
56. Schneider, H., B. Guerette, C. Guntermann, and C. E. Rudd. 2000. Resting lymphocyte kinase (Rlk/Txk) targets lymphoid adaptor SLP-76 in the cooperative activation of interleukin-2 transcription in T-cells. J. Biol. Chem. 275: 3835-3840. (Pubitemid 30094606)
57. Tomlinson, M. G., T. Kurosaki, A. E. Berson, G. H. Fujii, J. A. Johnston, and J. B. Bolen. 1999. Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk. J. Biol. Chem. 274: 13577-13585.
58. Lo, H. Y. 2010. Itk inhibitors: a patent review. Expert Opin. Ther. Pat. 20: 459-469.
59. Sahu, N., and A. August. 2009. ITK inhibitors in inflammation and immunemediated disorders. Curr. Top. Med. Chem. 9: 690-703.
60. Di Paolo, J. A., T. Huang, M. Balazs, J. Barbosa, K. H. Barck, B. J. Bravo, R. A. Carano, J. Darrow, D. R. Davies, L. E. DeForge, et al. 2011. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nat. Chem. Biol. 7: 41-50.
61. Uckun, F. M., and S. Qazi. 2010. Bruton's tyrosine kinase as a molecular target in treatment of leukemias and lymphomas as well as inflammatory disorders and autoimmunity. Expert Opin. Ther. Pat. 20: 1457-1470.
62. Honigberg, L. A., A. M. Smith, M. Sirisawad, E. Verner, D. Loury, B. Chang, S. Li, Z. Pan, D. H. Thamm, R. A. Miller, and J. J. Buggy. 2010. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc. Natl. Acad. Sci. USA 107: 13075-13080.